WallStreetZenWallStreetZen

How to Buy Coherus Biosciences Stock

Coherus Biosciences Inc

Coherus BioSciences, Inc. , a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States.

Coherus Biosciences stock last closed at $2.27, up 4.61% from the previous day, and has decreased 68.9% in one year. It has underperformed other stocks in the Biotechnology industry by 0.51 percentage points. Coherus Biosciences stock is currently +58.74% from its 52-week low of $1.43, and -72.38% from its 52-week high of $8.22.

At the moment, there are 112.71M CHRS shares outstanding. The market cap of CHRS is $255.86M. In the past 24 hours, 1.53M CHRS shares were traded.

How to Buy Coherus Biosciences Stock

Not sure how to invest in Coherus Biosciences stock? Here's how.
  1. Figure out where to buy Coherus Biosciences stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you choose where to buy Coherus Biosciences stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your investment account: Choose your method of payment and add your information.
  4. Evaluate Coherus Biosciences stock: The Coherus Biosciences ticker symbol is CHRS. Is Coherus Biosciences stock a good investment? Should you buy shares of CHRS? How do CHRS's underlying business fundamentals look? Do top analysts think Coherus Biosciences is a good buy? Why has CHRS's stock price moved recently? (Hint: Our stock research website can help you evaluate if CHRS is a good stock to buy).
  5. Make your CHRS trade: Decide if you will purchase CHRS shares at the current market price or use a limit order to buy CHRS shares at a particular price.
  6. Keep tabs on your investment in CHRS: Create a watchlist to key updates about your position in Coherus Biosciences shares.

Step 1: Figure out where to buy Coherus Biosciences stock

You need a brokerage account in order to access the NASDAQ market and buy CHRS stock.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

We believe that eToro is the best stock brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to world markets: From Tech to Energy, New York to Hong Kong — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro has a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by signing up for an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've chosen the right brokerage, the next step is to fill out some personal information so you are able to buy CHRS stock today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal data to create your new trading account.
  1. Send your application by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have filled out your info on the greatest app to buy stocks, your next step is to transfer the money for your investment:

Check out the tutorial below to see the process of transferring funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Coherus Biosciences stock

Once you have decided on the best place to buy Coherus Biosciences stock, it's absolutely critical to analyze their stock before you invest, so you truly wrap your head around the risk and upside.

Coherus Biosciences Numbers

CHRS Price
$2.27
1w %
11.27%
1y %
-68.9%
5y %
-86.14%
P/E
-0.9x
P/B
-1.32x
P/S
0.83x
PEG
N/A
Revenue
$257.24M
Earnings
-$237.89M
Fore. Rev. Growth
28.83%
Fore. Earn. Growth
N/A
Market Cap
$255.86M
Next Earnings
Jun 6, 2024
Next Dividend
N/A

Coherus Biosciences Due Diligence Checks

WallStreetZen was designed to help part-time investors do more in-depth fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on CHRS's stock page.

Is CHRS stock undervalued or overvalued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge CHRS's true value.

You can do more valuation research on CHRS's stock here.

CHRS Financial Health

Pros:

  • CHRS has $117.75M in cash and short term investments. This is enough to cover its annual cash burn of $174.33M.
  • There are more short-term assets than short-term liabilities on the CHRS balance sheet.

Cons:

  • CHRS has cash burn of 174325000. It does not have sufficient cash and short-term investments to cover this.
  • Total CHRS debt is still negative.
  • There are more long-term liabilities than short-term assets on the CHRS balance sheet.
  • CHRS profit margin has gone up by 0.46 percentage points in the past year, but the company is still unprofitable.
  • CHRS debt to equity ratio of -4.26 is negative.

Is it a good time to buy Coherus Biosciences stock, according to analysts?

Out of 3 sell side analysts who give forecasts on CHRS, the consensus analyst rating on CHRS is a Strong Buy

It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Coherus Biosciences stock forecast page.

CHRS Technical Indicators

SMA10
2.09
SMA20
2.18
SMA50
2.28
SMA100
2.38
SMA200
3.05
MACD
-0.06
MACD Signal
-0.08
MACD Histogram
0.02
RSI
53.69
Stochastic %K
64.71
Stochastic %D
41.4
StochRSI %K
98.63
StochRSI %D
77.13

CHRS Performance Metrics

Last year, CHRS revenue was $257.24M. In the last four year, CHRS's revenue has gone up by -7.81% per year. This was slower than the Biotechnology industry average of 29.63%.

Dive into CHRS's earnings and revenue performance here.

Who is buying/selling CHRS?

In the last 12 months, insiders at CHRS have bought more shares than they have sold.

Mats Wahlstrom, Director of CHRS, was the latest CHRS insider to buy. They bought $75,000.00 worth of CHRS shares on Feb 1, 2024.

Research more about who owns CHRS shares here.

Can I get consistent income from CHRS stock?

No, Coherus Biosciences doesn't provide an income stream by paying out dividends.

CHRS Social Trading Data

One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Make your CHRS trade

There are two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually sufficient.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a particular price limit, place a limit order.

Click the Open button and your broker will execute the order.

If you need additional help with investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Keep tabs on your investment in CHRS

Now that you own some CHRS stock, you'll want to keep up with your stock purchase.

Make a watchlist to get the latest updates about your CHRS stock.

CHRS Feed

How to Buy Stock in Coherus Biosciences

To summarize, here are the 6 steps to buy stock in Coherus Biosciences:

  1. Figure out where to buy Coherus Biosciences stock
  2. Sign up for your brokerage account
  3. Deposit funds into your investment account
  4. Evaluate Coherus Biosciences stock
  5. Make your CHRS trade
  6. Keep tabs on your investment in CHRS

If you need a brokerage account, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to track your new investment in Coherus Biosciences, get started below.

NASDAQ: CHRS
$2.27+0.10 (+4.61%)
Updated May 3, 2024
Open eToro Account
NASDAQ: CHRS
$2.27+0.10 (+4.61%)
Updated May 3, 2024
Open eToro Account

FAQ

How much does it cost to buy one Coherus Biosciences share?

As of May 3, 2024, it costs $2.27 to buy one share of Coherus Biosciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.441 shares of CHRS.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Coherus Biosciences stock?

According to 3 Wall Street analysts who monitor Coherus Biosciences, their consensus recommendation is to buy Coherus Biosciences stock.

What is the best way to buy Coherus Biosciences stock?

One way to place an order for Coherus Biosciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.